Investec Bank plc has filed a Form 8.5 regulatory disclosure revealing significant share dealings in Advanced Medical Solutions Group plc (AMS.L) on 16th July 2026.
The disclosure was made under Rule 8.5 of the Takeover Code, which governs public dealing disclosures by exempt principal traders with recognised intermediary status.
Investec Bank plc submitted the filing in its capacity as an exempt principal trader dealing in a client-serving capacity during the relevant period.
The bank holds a dual role in relation to Advanced Medical Solutions Group plc, serving as both advisor and joint broker to the company throughout this process.
On 16th July 2026, Investec purchased a total of 2,584,574 ordinary shares in Advanced Medical Solutions Group at a price of 279 pence per unit.
The bank also recorded sales of 2,689,727 ordinary shares, with prices ranging between 279 and 279.5 pence per unit on the same trading day.
No cash-settled derivative transactions or stock-settled derivative transactions were reported as part of the filing for this disclosure period.
Investec confirmed there are no indemnity or option arrangements, nor any agreements or understandings that may constitute an inducement to deal or refrain from dealing.
The bank also confirmed no agreements or understandings exist relating to voting rights or future acquisition and disposal of relevant securities linked to any derivative.
The disclosure was formally submitted on 17th July 2026, with contact for the filing attributed to Abhishek Gawde, reachable at the telephone number provided within the regulatory notice.
Advanced Medical Solutions Group plc (AMS.L) saw its shares move marginally, reflecting the scale of trading activity recorded by Investec during the disclosed dealing period.
Such filings are a standard regulatory requirement under the Takeover Code, ensuring transparency in share dealings during offer periods involving publicly listed companies.
